ArticleVaccine2025

BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice.

Matthew E Sherman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.